Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. SILO Pharma Inc. (SILO) Message Board

Machine Learning Model Enables Researchers to Pinp

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 138
(Total Views: 147)
Posted On: 04/18/2022 5:41:04 PM
Avatar
Posted By: NetworkNewsWire
Machine Learning Model Enables Researchers to Pinpoint PTSD Sufferers

Researchers have designed a machine learning model that can identify individuals suffering from PTSD by conducting an analysis of text data with 80% accuracy. Post-traumatic stress disorder (PTSD) is a mental health condition that is triggered by a traumatic event which an individual may witness or experience.

This machine learning model may, in the future, be used as an inexpensive and accessible screening method to help physicians detect and diagnose post-traumatic stress disorder or other mental conditions, via telehealth platforms. Jeff Sawalha, a PhD candidate specializing in psychiatry at the University of Alberta, led this project. He carried out an analysis of text obtained from a dataset developed by a researcher at the Institute for Creative Technologies in USC. This sentiment analysis involved categorizing a huge body of data comprised of interview responses gathered over video conferencing calls with individuals who did and did not suffer from PTSD.

Sawalha stated that the objective of the study was to see whether the model could accurately identify people with post-traumatic stress disorder, based on the emotional content of the data. The researchers succeeded in determining the people with PTSD using scores that indicated whether these individuals’ speeches primarily featured negative or neutral responses.

Sawalha explained that this was in line with literature on post-traumatic stress disorder and emotion, noting that while some individuals had no issue expressing their negative emotions, others tended to numb their emotions, be neutral and refrain from saying too much.

The coauthor of the study, Russ Greiner of the Department of Computing Science, highlighted that this process to identify individuals with PTSD was complicated, given that the abundance in simple phrases could be hard to categorize. Greiner is scientific director for the Alberta Machine Intelligence Institute.

However, the model’s success in identifying those with post-traumatic stress disorder solely from text data posits that similar models can be applied to other sets of data to identify individuals suffering from other mental health conditions. Sawalha noted that machine learning also made it easier to learn the complex patterns that could help differentiate individuals who suffered from a specific mental illness.

The researchers are now focused on collaborating with partners at the University of Alberta in order to find out whether integrating other data types, such as motion or speech, could improve the model. They also hope to analyze mental health conditions such as schizophrenia and neurological disorders such as Alzheimer’s, which have a language component.

As the diagnostic tools for various mental health conditions improve, there is also a need to speed up the development of new lines of treatment for these illnesses. Entities such as Silo Pharma Inc. (OTCQB: SILO) are responding to this need, and breakthroughs are imminent in the coming years.

NOTE TO INVESTORS: The latest news and updates relating to Silo Pharma Inc. (OTCQB: SILO) are available in the company’s newsroom at https://ibn.fm/SILO

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer





(0)
(0)




SILO Pharma Inc. (SILO) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us